![[ Beasley Allen Law Firm Logo ]](http://www.sjs-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}
Flu treatment and prevention drug linked to serious allergic reaction
A medicine used to treat and help prevent the flu may put patients at risk for a rare but life-threatening condition in which the skin peels off the body in sheets, according to the Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research. The agency notified the public that it has approved safety label changes for Relenza (zanamivir) Inhalation Powder for oral inhalation. The Adverse Reactions section of the drug’s new safety label now includes a risk of rash, including serious cutaneous reactions (e.g. erythema multiforme, Stevens Johnson Syndrome, SJS, and toxic epidermal necrolysis, TEN).
Researchers are reportedly saying that antiviral medications Tamiflu and Relenza could help curb the intensity and effects of the swine flu for those who appear to becoming ill, however some doctors are warning that the antiviral drugs should only be taken if prescribed by a physician otherwise other serious conditions may arrise, according to 